{"id":"https://openalex.org/A5012804790","orcid":"https://orcid.org/0000-0002-8269-9526","observed_orcids":["https://orcid.org/0000-0002-8269-9526"],"display_name":"Mohamed K. Elgohary","raw_author_names":["Elgohary, Mohamed K.","Mohamed Elgohary","Mohamed K. Elgohary"],"full_name":"Mohamed  Khaled Elgohary","works_count":31,"cited_by_count":381,"summary_stats":{"2yr_mean_citedness":11.733333333333333,"h_index":13,"i10_index":15},"ids":{"openalex":"https://openalex.org/A5012804790","orcid":"https://orcid.org/0000-0002-8269-9526","observed_orcids":["https://orcid.org/0000-0002-8269-9526"]},"affiliations":[{"institution":{"id":"https://openalex.org/I67337280","ror":"https://ror.org/029me2q51","display_name":"Egyptian Russian University","country_code":"EG","type":"education","lineage":["https://openalex.org/I67337280"]},"years":[2026,2025,2024,2023]}],"last_known_institutions":[{"id":"https://openalex.org/I67337280","ror":"https://ror.org/029me2q51","display_name":"Egyptian Russian University","country_code":"EG","type":"education","lineage":["https://openalex.org/I67337280"]}],"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","count":30,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","count":18,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","count":16,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","count":8,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","count":4,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","value":8.88e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","value":8.41e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12318","display_name":"Quinazolinone synthesis and applications","value":4.4e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","value":3.93e-05,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","value":3.51e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.9758931398391724},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.6922447085380554},{"id":"71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","score":0.5882431864738464},{"id":"21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","score":0.5449693202972412},{"id":"55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","score":0.4424999952316284}],"counts_by_year":[{"year":2023,"works_count":1,"oa_works_count":0,"cited_by_count":1},{"year":2024,"works_count":12,"oa_works_count":5,"cited_by_count":34},{"year":2025,"works_count":9,"oa_works_count":4,"cited_by_count":160},{"year":2026,"works_count":9,"oa_works_count":6,"cited_by_count":186}],"display_name_alternatives":["Elgohary, Mohamed K.","Mohamed Elgohary","Mohamed K. Elgohary"],"block_key":"m elgohary","works_api_url":"https://api.openalex.org/works?filter=author.id:A5012804790","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5012804790","updated_date":"2026-11-12T13:17:38","created_date":"2023-07-09T00:00:00"}